Papers
1
Total Citations
20
H-Index
1
About
David Ferry is a pioneering surgical oncologist whose research focuses on advancing minimally invasive techniques in breast cancer surgery, particularly through the development and evaluation of robot-assisted nipple-sparing mastectomy (RNSM). His major contributions center on improving oncologic safety and cosmetic outcomes for patients, with a key study—"Residual breast tissue after robot-assisted nipple sparing mastectomy" (2020, 20 citations)—establishing a critical surrogate marker for surgical completeness. By histologically assessing residual breast tissue (RBT) post-procedure, Ferry provided foundational evidence that RNSM can achieve oncologically sound resections while preserving the nipple-areola complex, addressing a long-standing concern in breast conservation. This work has shaped clinical guidelines and inspired further research into robotic breast surgery, with his findings cited in subsequent studies exploring long-term safety and patient satisfaction. Ferry’s dedication to merging surgical precision with patient-centered care positions him as a leader in the field, driving innovation that balances radical cancer control with quality-of-life preservation. His ongoing investigations continue to refine robotic techniques, offering hope for less invasive yet equally effective treatments.
Research Focus
Key Achievements
Top Papers
- 1Residual breast tissue after robot-assisted nipple sparing mastectomy20 citations · 2020